Document:

Offer letter dated January 31, 1997

 Exhibit 10.27 
 ORACLE (Suisse) 
 Davos, January 31 1997 
 Mr. Sergio Giacoletto 
 14, Chemin des Cotes 
 1233 Bernex 
 Switzerland 
 Dear Sergio, 
 I am delighted to offer you the position of Vice - President Alliances in Oracle E.M.E.A. You will be based in
Geneva, employed by Oracle Switzerland. We may create a separate entity from Oracle Switzerland to cover the EMEA activities. In that case your employment will be transferred to the new entity under the identical conditions of this offer.

 The conditions of your employment are as follows: 
  

			
	On Target Earning :	  	your annual base salary will be Sfr. 300’000.00 paid in 13 months. Your incentive will be Sfr. 180’000.00 at target based on an agreed yearly plan. Up to May 31 1997, you will
be paid at your monthly 100% O.T.E.
		
	Medical, illness, disability and pension plan:	  	You will receive the same conditions as per your actual employer and the same insurance company. You will provide to the Suisse Human Resources department a copy of your coverages and the
contact of Mr: Grandchamp to formalize the coverage.
		
	Car allowance:	  	You will be provided with the same conditions you have with your existing employer
		
	Stock options:	  	We will request to the Board of Directors of Oracle to grant you 15000 shares according to standard rules and regulations of the company.

 Letter to Sergio Giacoletto 
 page 2 
 Your starting date will be
March 1 1997. 
 It is a great pleasure and honor for me to work again with you to build a strong Oracle EMEA. 
 I look forward to receive back a copy of this letter in sign of agreement. 
 Enjoy your vacations and thanks for your trust. 
  

	
	Best regards,
	
	 /s/ Pier Carlo Falotti

	Pier Carlo Falotti

 

 
  

 EMPLOYMENT AGREEMENT 
 concluded between 
 ORACLE Software (Switzerland) Ltd. 
 Oracle House, Täfernstrasse 4 
 5405 Baden-Dättwil 
 (hereinafter referred to as the “company”) 
 and 
 Mr Sergio Giacoletto 

14, Chemin des Cotes 
 1233 Bernex

 (hereinafter referred to as the “employee”) 
 February 20th, 1997 

 

 
  

 The employee shall assume the position of Vice President Alliances, EMEA (100%) under the following terms
and conditions: 
  

			
	Direct report:	  	Senior Vice President EMEA
		
	Place of work:	  	Geneva
		
	Starting date:	  	March 1st, 1997

 Probationary Period 
 The first three months of employment are on a probationary basis. During this period, either party may terminate this agreement by giving an advance notice of one week. 
 Notice Period for Termination 
 During the first year of
employment the notice period for termination is one month, as of the second year of employment it is three months both as per the end of a month. The notice periods apply mutually. 
 Employee’s Obligations 
 The employee shall carefully
perform the work assigned to him/her and loyally safeguard the company’s legitimate interests. 
 During the employment the employee is not permitted to
enter, into activities active compete with the company’s business. Business and trade secrets shall not be disclosed or used otherwise by the employee without the company’s express consent. 
 Working Hours 
 The minimum working hours for full
time-employees are 40 hours per week. For employees in a part time position the working hours are reduced in relation to their percentage of employment. However, the company expects its employees to complete their assignments in accordance with
ORACLE’s high quality standards and in a timely manner. 
  

 2 

 

 
  

 Confidentiality Clause 
 The employment creates a relationship of confidence and trust between the employee and the company with respect to certain information of a confidential, proprietary or trade secret nature which gives the company a
competitive edge in its business. For the purpose of this agreement, all such confidential, proprietary or trade secret information will be referred to as “Proprietary Information”. 
 The imposed secrecy refers in particular to customer data transmitted to the company’s attention. 
 The software products provided by ORACLE Corporation, Redwood Shores, CA, USA, such as dateline communications, handbooks, supporting documentation (technical or market
strategic) are the sole property of ORACLE Corporation, Redwood Shores. Market strategic and internal confidential information are only to be transmitted to third parties with the written consent of the company. 
 The employee acknowledges that a violation of these provisions would justify the immediate termination of this employment agreement according to Article 337 of the Swiss
Code of Obligations. 
 At all times, both during and after the employment, the employee will hold Proprietary Information in confidence. He/she will not
use, transfer, publish, disclose or report Proprietary Information directly or indirectly, except such disclosure to other ORACLE employees or authorised third parties as may be necessary in the ordinary course of performing his/her duties for the
company. 
 Discovery Clause 
 The employee will
promptly disclose to the company all ideas, processes, inventions, modifications, and improvements (collectively referred to as “Discoveries”) relating to any work or business carried out by the company, conceived by the employee
him/herself or with others during the term, of the employment, whether or not conceived during regular business hours. 
 The company shall have the option
to obtain exclusive property in such Discoveries. The employee agrees to execute all formal documents necessary to assign any Discoveries to the company as well as all documents required to obtain a patent, register a copyright, or enforce
company’s rights to such Discoveries should the company desire to obtain respective rights. 
 In case of the company’s adoption of the Discovery
pursuant to Article 332 of the Swiss Code of Obligations the employee shall receive a compensation. 
 The obligations shall remain effective beyond the
termination of employment with respect to Discoveries the employee conceives or makes during the employment period. 
  

 3 

 

 
  

 Developments 
 For employees which are or potentially may be engaged in (co-) developing program code and/or conjunctive documentation (collectively referred to hereinafter as “Developments”) for the company or its customers, the following shall
apply: 
 Any and all Developments which the employee may generate while fulfilling his/her employment agreement shall be or become the full property of
ORACLE as far as this is not automatically provided by law. To the extent necessary and permissible by law the employee agrees to transfer to ORACLE and/or waive any such intellectual property rights. 
 Avocational Occupation 
 During the employment relationship,
the employee shall neither perform work for third parties against compensation nor perform work on his/her own account to the extent such work conflicts with his duty of loyalty, and, in particular, to the extent it may compete with his/her company.
The employee shall not offer products or services outside the range of those offered by the company. 
 Avocational occupation must be approved by the
company. The employee acknowledges that a breach of this provision would justify the termination without notice period as provided in Art. 337 of the Swiss Code of Obligations. 
 Vacation 
 The vacation entitlement for full time-employees is 25 working days per Fiscal Year during the first
three years of employment. During the forth and fifth year the entitlement is 26 working days, during the sixth and seventh year 27 working days and from the eighth year on 28 working days per Fiscal Year, For employees who are older than 50 years
the yearly entitlement is 28 working days per Fiscal Year. For employees in a part time position the entitlement will be reduced in relation to their percentage of employment. 
 The vacation entitlement will be pro-rated in the event the employment starts or ends during a Fiscal Year. 
 Official
holidays within the employee’s vacation period shall be added to his/her vacation entitlement. 
 Vacation dates and their respective duration shall be
agreed upon mutually in order to take the employee’s desires as well as the company’s interests into adequate consideration. 
  

 4 

 

 
  

 Remuneration 
  

			
	Your On Target Earning (OTE) will be	  	SFr. 480’000.–, composed as follows:
	Base salary (paid 13 x p.a.)	  	SFr. 300’000.—
	Variable	  	SFr. 180’000.—

 The 13th monthly salary will be pro-rated according to your starting or termination date. The variable part of the
OTE will be guaranteed during the 3 months after the starting date (i.e. May 31st l997). 
 The Target Sheet is an integral part of this agreement and defines the target income for each Fiscal year separately. In absence of a new target sheet the arrangement
for the previous year shall apply. 
 Military Service 
 The company shall pay the full salary up to four weeks in the event of compulsory military service. Salary payments during voluntary military service may be continued upon the company’s approval on a case to case basis. 
 Expenses 
 Your business expenses will be reimbursed in
accordance with our Expenses Regulations. 
 Car Allowance 
 Please refer to letter dated January 31st 1997 signed by Pier Carlo Falotti. 
 Illness Insurance 
 Please refer to letter dated
January 31st 1997 signed by Pier Carlo Falotti. 
 Please provide the company with a copy of your insurance policy. 
 Pension Plan 
 Please refer to letter dated January 31st 1997 signed by Pier Carlo Falotti. 
  

 5 

 

 
  

 Accident- and Sickness Benefit-Insurance 
 Please refer to letter dated January 31st 1997 signed by Pier Carlo Falotti.

 Compulsory Insurances (AHV, ALV, etc.) 
 50% of
the charges will be paid by the company. 
 Regulations 
 The employee confirms by signing that he/she has received all the regulations mentioned in this employment agreement. 
  

							
	Company:	 		  	Employee:	  	
				
	Baden-Därttwil,	 	12.3.97	  	Place/Date:	  	 Bemex, 27/2/97

				
	Signature:	 		  	Signature:	  	/s/ Sergo Giacoletto
			
	ORACLE Software (Switzerland) Ltd.	  		  	

  

							
	 /s/ P.C. Farom
	 		  	 /s/ Th Sager
	  	
	P.C. Farom	 		  	Th Sager	  	  

 Enclosures mentioned 
 In duplicate 
  

 6Exhibit 4.1

 Exhibit 4.1 
 PRICING INSTRUMENT 
 WHEREAS, the parties named herein desire to enter into certain Program Documents
(as defined herein) contained herein, each such document (unless otherwise specified in such document) dated as of the date of the Pricing Supplement (attached to this Pricing Instrument as Exhibit C) (the “Pricing Supplement”), relating
to the issuance by Genworth Global Funding Trust 2006-E (the “Trust”) of Notes to investors under the secured notes program sponsored by Genworth Life and Annuity Insurance Company (“GLAIC”); 
 WHEREAS, the Trust is a trust and will be organized under and its activities will be governed by the provisions of the Trust Agreement (set forth in
Section A of this Pricing Instrument), dated as of the date of the Pricing Supplement, by and between the parties thereto indicated in Section E herein; 
 WHEREAS, certain expense and indemnification arrangements between GLAIC and the Trustee, on behalf of itself and on behalf of the Trust, are governed pursuant to the provisions of the Expense and Indemnity Agreement
dated as of December 7, 2005, by and between GLAIC and the Trustee; 
 WHEREAS, certain licensing arrangements between the Trust and
Genworth Financial, Inc. will be governed pursuant to the provisions of the License Agreement dated as of October 28, 2005, by and between the Trust and Genworth Financial, Inc.; 
 WHEREAS, certain custodial arrangements for the Funding Agreement will be governed pursuant to the provisions of the Custodial Agreement (the
“Custodial Agreement”) dated as of December 7, 2005 by and among SunTrust Bank, acting as custodian (the “Custodian”), the Indenture Trustee and the Trust; 
 WHEREAS, the Notes will be issued pursuant to the Indenture (set forth in Section B of this Pricing Instrument), dated as of the Original Issue Date, by
and between the parties thereto indicated in Section E herein; 
 WHEREAS, the sale of the Notes will be governed by the Terms Agreement (set
forth in Section C of this Pricing Instrument), dated as of the date of the Pricing Supplement, by and among the parties thereto indicated in Section E herein; and 
 WHEREAS, certain agreements relating to the Notes and the Funding Agreement are set forth in the Coordination Agreement (set forth in Section D of this Pricing Instrument), dated as of the date of the Pricing
Supplement, by and among the parties thereto indicated in Section E herein. 
 All capitalized terms used herein and not otherwise defined
will have the meanings set forth in the Indenture. 
  

 1 

 SECTION A 
 TRUST AGREEMENT 
 This TRUST AGREEMENT (this “Trust Agreement”), dated as of the date of the
Pricing Supplement, is entered into by and between GSS Holdings II, Inc., a Delaware corporation, as trust beneficial owner (the “Trust Beneficial Owner”), and The Bank of New York, a New York banking corporation, as Trustee (the
“Trustee”). 
 WITNESSETH: 
 WHEREAS, the Trust Beneficial Owner and the Trustee desire to authorize the issuance of a Trust Beneficial Interest and a series of Notes in connection with the entry into this Trust Agreement; 
 WHEREAS, all things necessary to make this Trust Agreement a valid and legally binding agreement of the Trustee and the Trust Beneficial Owner,
enforceable in accordance with its terms, have been done; 
 WHEREAS, the parties intend to provide for, among other things, (i) the
issuance and sale of the Notes (pursuant to the Indenture, the Distribution Agreement and the related Terms Agreement) and the Trust Beneficial Interest, (ii) the use of the proceeds of the sale of the Notes and Trust Beneficial Interest to
acquire the Funding Agreement, and (iii) all other actions deemed necessary or desirable in connection with the transactions contemplated by this Trust Agreement; and 
 WHEREAS, the parties hereto desire to incorporate by reference those certain Standard Trust Terms, dated as of December 8, 2005, and attached to the
Pricing Instrument as Exhibit A (the “Standard Trust Terms”). 
 NOW, THEREFORE, in consideration of the agreements and obligations
set forth herein and for other good and valuable consideration, the sufficiency of which are hereby acknowledged, each party hereby agrees as follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by Reference. All terms, provisions and agreements set forth
in the Standard Trust Terms (except to the extent expressly modified herein) are hereby incorporated herein by reference with the same force and effect as though fully set forth herein. All capitalized terms not otherwise defined herein (including
the recitals hereof) shall have the meanings set forth in the Standard Trust Terms (the Standard Trust Terms and this Trust Agreement, collectively, the “Trust Agreement”). To the extent that the terms set forth in Article 2 of this Trust
Agreement are inconsistent with the terms of the Standard Trust Terms, the terms set forth in Article 2 herein shall apply. 
  

 A-1 

 ARTICLE 2 
 Section 2.01 Name. The Trust created and governed by this Trust Agreement shall be the trust specified in the Pricing Instrument. The name of the Trust shall be the name specified in the first paragraph of the
Pricing Instrument, as such name may be modified from time to time by the Trustee following written notice to the Trust Beneficial Owner. 
 Section 2.02 Jurisdiction. The Trust is hereby organized in, and formed under and pursuant to, the laws of the jurisdiction specified in the Pricing Supplement. 
 Section 2.03 Initial Capital Contribution and Ownership. The Trust Beneficial Owner has paid or has caused to be paid to, or to an account at the
direction of, the Trustee, on the date hereof, the sum of $15 (or, in the case of Notes issued with original issue discount, such amount multiplied by the issue price of the Notes as specified in the Pricing Supplement). The Trustee hereby
acknowledges receipt in trust from the Trust Beneficial Owner, as of the date hereof, of the foregoing contribution, which shall be used along with the proceeds from the sale of the series of Notes to purchase the Funding Agreement. Upon the
creation of the Trust and the registration of the Trust Beneficial Interest in the Securities Register (as defined in the Trust Agreement) by the Trust Registrar in the name of the Trust Beneficial Owner, the Trust Beneficial Owner shall be the sole
beneficial owner of the Trust. 
 Section 2.04 Acknowledgment. The Trustee, on behalf of the Trust, expressly acknowledges its duties
and obligations set forth in the Standard Trust Terms incorporated herein by reference. 
 Section 2.05 Additional Terms. 

None. 
 Section 2.06 Pricing
Instrument; Execution and Incorporation of Terms. 
 The parties hereto will enter into the Trust Agreement by executing the Pricing
Instrument. 
 By executing the Pricing Instrument, the Trustee and the Trust Beneficial Owner hereby agree that the Trust Agreement will
constitute a legal, valid and binding agreement between the Trustee and the Trust Beneficial Owner. 
 All terms relating to the Trust or the
series of Notes not otherwise included herein will be as specified in the Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 2.07 Governing Law. This Trust Agreement will be governed by, and construed in accordance with, the laws of the jurisdiction specified in the Pricing Supplement. 
 Section 2.08 Counterparts. The Trust Agreement, through the Pricing Instrument, may be executed in any number of counterparts, each of which
counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
  

 A-2 

 SECTION B 
 INDENTURE 
 This INDENTURE (this “Indenture”) is entered into as of the Original Issue Date by and
between the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”) and JPMorgan Chase Bank, N.A., as indenture trustee (the “Indenture Trustee”). 
 JPMorgan Chase Bank, N.A., in its capacity as Indenture Trustee, hereby accepts its role as Registrar, Paying Agent, Transfer Agent and Calculation Agent
hereunder. 
 References herein to “Indenture Trustee,” “Registrar,” “Transfer Agent,” “Paying Agent”
or “Calculation Agent” shall include the permitted successors and assigns of any such entity from time to time. 
 WITNESSETH:

 WHEREAS, the Trust has duly authorized the execution and delivery of this Indenture to provide for the issuance of Notes; 
 WHEREAS, all things necessary to make this Indenture a valid and legally binding agreement of the Trust and the other parties to this Indenture,
enforceable in accordance with its terms, have been done, and the Trust proposes to do all things necessary to make the Notes, when executed by the Trust and authenticated and delivered pursuant hereto, valid and legally binding obligations of the
Trust as hereinafter provided; and 
 WHEREAS, the parties hereto desire to incorporate by reference those certain Standard Indenture Terms,
dated as of December 8, 2005, and attached to the Pricing Instrument as Exhibit B (the “Standard Indenture Terms”). 
 NOW, THEREFORE, for and in consideration of the premises and the purchase of the Notes by the Holders thereof, it is mutually covenanted and agreed by each of the parties hereto as follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by
Reference. All terms, provisions and agreements set forth in the Standard Indenture Terms (except to the extent expressly modified herein) are hereby incorporated herein by reference with the same force and effect as though fully set forth
herein. All capitalized terms not otherwise defined herein (including the recitals hereof) shall have the meanings set forth in the Standard Indenture Terms (the Standard Indenture Terms and this Indenture, collectively, the “Indenture”).
To the extent that the terms set forth in Article 2 of this Indenture are inconsistent with the terms of the Standard Indenture Terms, the terms set forth in Article 2 herein shall apply. 
  

 B-1 

 Article 2 
 Section 2.01 Agreement to be Bound. Each of the Trust, the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent and the Calculation Agent hereby agrees to be bound by all of the terms,
provisions and agreements set forth in the Indenture, with respect to all matters contemplated in the Indenture, including, without limitation, those relating to the issuance of the below-referenced Notes. 
 Section 2.02 Designation of the Trust, the Notes and the Funding Agreement. The Trust created by the Trust Agreement specified in the Pricing
Instrument and referred to herein is the Genworth Global Funding Trust specified in the Pricing Instrument. The Notes issued by the Trust and governed by the Indenture shall be the Notes specified in the Pricing Supplement. The Funding Agreement
designated hereby is the Funding Agreement designated in the Pricing Supplement, effective as of the Original Issue Date, between the Trust and Genworth Life and Annuity Insurance Company. 
 Section 2.03 Additional Terms. 
 None. 
 Section 2.04 Pricing Instrument; Execution and Incorporation of Terms. 
 The parties hereto will enter into this Indenture by executing the Pricing Instrument. 
 By executing the Pricing Instrument, the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the Calculation Agent and the Trust
hereby agree that the Indenture will constitute a legal, valid and binding agreement between the Indenture Trustee, the Registrar, the Transfer Agent, the Paying Agent, the Calculation Agent and the Trust. 
 All terms relating to the Trust or the Notes not otherwise included herein will be as specified in the Pricing Instrument or Pricing Supplement, as
indicated herein. 
 Section 2.05 Counterparts. This Indenture, through the Pricing Instrument, may be executed in any number of
counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute one and the same instrument. 
 [Remainder of Page Left Intentionally Blank] 
  

 B-2 

 SECTION C 
 TERMS AGREEMENT 
 This TERMS AGREEMENT (this “Terms Agreement”) is entered into as of the date of
the Pricing Supplement by and among Genworth Life and Annuity Insurance Company (“GLAIC”), the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”) and the Agents specified in the Pricing Supplement
(the “Agents”). 
 W I T N E S S E T H: 
 WHEREAS, GLAIC and the Agents have entered into that certain Distribution Agreement dated December 9, 2005 (the “Distribution Agreement”). 
 NOW, THEREFORE, in consideration of the mutual promises set forth herein and other good and valuable consideration, the sufficiency and receipt of which
are hereby acknowledged, each of the parties hereby agrees as follows: 
 ARTICLE 1 
 Section 1.01 Incorporation by Reference. The provisions of the Distribution Agreement and the related definitions (unless otherwise specified
herein) are incorporated by reference herein and shall be deemed to have the same force and effect as if set forth in full herein. 
 ARTICLE
2 
 Section 2.01 Addition of Trust as Party to Distribution Agreement. 
 Pursuant to Section 1 of the Distribution Agreement, each of the undersigned parties hereby acknowledges and agrees that the Trust, upon execution
hereof by the Trust and the other parties to this Terms Agreement, shall become a Trust for purposes of the Distribution Agreement in accordance with the terms thereof, in respect of the Notes, with all the authority, rights, powers, duties and
obligations of a Trust under the Distribution Agreement. The Trust confirms that any agreement, covenant, acknowledgment, representation or warranty under the Distribution Agreement applicable to the Trust is made by the Trust at the date hereof,
unless another time or times are specified in the Distribution Agreement, in which case such agreement, covenant, acknowledgment, representation or warranty shall be deemed to be confirmed by the Trust at such specified time or times. 
 All references to Section 9 (Indemnification) of the Distribution Agreement to “solely with respect to the applicable Agent(s) or
Co-Agent(s)” will include all of such Agent’s or Co-Agent’s directors and officers and each person, if any, who controls such Agent or Co-Agent within the meaning of Section 15 of the Securities Act of 1933, as amended or
Section 20 of the Securities Exchange Act of 1934, as amended. All references in the Distribution Agreement to the “Registration Statement”, the “Institutional Base Prospectus”, the “Retail Base Prospectus”, any
“preliminary prospectus”, the “Time of Sale Prospectus” and the “Prospectus” shall also be deemed to include all documents incorporated by reference therein. 
  

 C-1 

 Section 2.02 Purchase of Notes as Principal. 
 (a) Subject in all respects to the terms and conditions of the Distribution Agreement, the Trust hereby agrees to sell to each Agent and each Agent
hereby agrees to purchase, severally and not jointly, the Notes having the terms specified in the Pricing Supplement relating to such Notes. 
 (b) In connection with any purchase of Notes from the Trust by the Agent(s) as principal, the parties agree that the items specified on Schedule I of the Pricing Instrument will be delivered as of the Settlement Date. 
 Section 2.03 Termination. Upon the termination of this Terms Agreement pursuant to Section 13(b) of the Distribution Agreement the
undersigned parties hereby agree to allocate the expenses reasonably incurred prior to or in connection with such termination as follows: 
 The expenses will be borne by GLAIC. 
 Section 2.04 Applicable Time. For purposes of the Distribution Agreement, the
Applicable Time shall be 11:02 am EST, September 18, 2006. 
 Section 2.05 Governing Law. This Terms Agreement shall be
governed by and construed in accordance with the laws of the State of New York without regard to the principles of conflicts of laws thereof. 
 Section 2.06 Notices. For purposes of Section 14 of the Distribution Agreement, the Trust’s communications details are as set forth in Section D of the Pricing Instrument. 
 Section 2.07 Additional Terms. Each Agent, severally and not jointly, represents, warrants and covenants with or to (as the case may be) the
Trust and the Company that it has not offered, sold or delivered and it will not offer, sell or deliver, any of the Notes, in or from any jurisdiction except under circumstances that are reasonably designed to result in compliance with the
applicable securities laws and regulations thereof. 
 Section 2.08 Pricing Instrument; Execution and Incorporation of Terms.

 The parties hereto will enter into this Terms Agreement by executing the Pricing Instrument. 
 By executing the Pricing Instrument, each party hereto agrees that this Terms Agreement will constitute a legal, valid and binding agreement by and among
such parties. 
 All terms relating to the Trust or the Notes not otherwise included in this Terms Agreement will be as specified in the
Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 2.09 Counterparts. This Terms Agreement, through the
Pricing Instrument, may be executed in any number of counterparts, each of which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
  

 C-2 

 EXHIBIT A 
 Free Writing Prospectus (attached) 
  

 C-3 

 SECTION D 
 COORDINATION AGREEMENT 
 This COORDINATION AGREEMENT (this “Coordination Agreement”), dated as of
the date of the Pricing Supplement, is entered into by and among Genworth Life and Annuity Insurance Company (“GLAIC”), the Genworth Global Funding Trust specified in the Pricing Instrument (the “Trust”), SunTrust Bank, in its
capacity as custodian of the Funding Agreement (“Custodian”) and JPMorgan Chase Bank, N.A., as indenture trustee (the “Indenture Trustee”). 
 W I T N E S S E T H 
 WHEREAS, the Trust will enter into the Funding Agreement with GLAIC, effective as of
the Original Issue Date specified in the Pricing Supplement; 
 WHEREAS, the Agent(s) (as defined in the Distribution Agreement) will sell
the Notes in accordance with the Registration Statement; 
 WHEREAS, the Trust intends to issue the Notes in accordance with the Indenture,
to collaterally assign to, and grant a security interest in, the Funding Agreement to and in favor of the Indenture Trustee in accordance with the Indenture to secure payment of the Notes; and 
 WHEREAS, the Custodian will hold the Funding Agreement on behalf of the Indenture Trustee pursuant to the terms of the Custodial Agreement. 

NOW, THEREFORE, to give effect to the agreements and arrangements established under the Terms Agreement included in the Pricing Instrument, as
applicable, the Trust Agreement, the Indenture and the Notes, and in consideration of the agreements and obligations set forth herein and for other good and valuable consideration, the sufficiency of which are hereby acknowledged, each party hereby
agrees as follows: 
 ARTICLE 1 
 Section 1.01 Delivery of the Funding Agreement. The Trust hereby authorizes the Custodian, on behalf of the Indenture Trustee, to receive the Funding Agreement from GLAIC pursuant to the assignment of the Funding Agreement (the
“Assignment”), to be entered into on the Original Issue Date, included in the closing instrument dated as of the Original Issue Date (the “Closing Instrument”). 
 Section 1.02 Issuance and Purchase of the Notes. 
 (a) Delivery of the Funding Agreement to the Custodian, on behalf of the Indenture Trustee, pursuant to the Assignment or execution of the cross-receipt contained in the Closing Instrument shall be confirmation of
payment by the Trust for the Funding Agreement. 
 (b) The Trust hereby directs the Indenture Trustee, upon receipt of the Funding Agreement
by the Custodian, on behalf of the Indenture Trustee and pursuant to the Assignment, (i) to authenticate the certificates representing the Notes (the “Certificates”) in accordance with 

  

 D-1 

 
the Indenture and (ii) to (A) deliver each relevant Certificate to the clearing system or systems identified in each such Certificate, or to the
nominee of such clearing system, or the custodian thereof, for credit to such accounts as the Agent(s) may direct, or (B) deliver each relevant Certificate to the purchasers thereof as identified by the Agent(s). 
 ARTICLE 2 
 Section 2.01 Directions
Regarding Periodic Payments. As registered owner of the Funding Agreement as collateral securing payments on the Notes, the Indenture Trustee will receive payments on the Funding Agreement on behalf of the Trust. The Trust hereby directs the
Indenture Trustee to use such funds to make payments on behalf of the Trust pursuant to the Trust Agreement and the Indenture. 
 Section
2.02 Maturity of the Funding Agreement. Upon the maturity of the Funding Agreement and the return of funds thereunder, the Trust hereby directs the Indenture Trustee to set aside from such funds an amount sufficient for the repayment of the
outstanding principal on the Notes and Trust Beneficial Interest when due. 
 ARTICLE 3 
 Section 3.01 Officer’s Certificates. GLAIC hereby agrees to deliver an Officer’s Certificate, a copy of which is attached hereto as
Exhibit D, on a quarterly basis to any rating agency currently rating the Program. The Trust hereby agrees to deliver an Officer’s Certificate, a copy of which is attached to the Pricing Instrument as Exhibit E, on a quarterly
basis to any rating agency currently rating the Program. 
 Section 3.02 Filings. GLAIC hereby covenants to file, or cause to be
filed, in a timely manner on behalf of the Trust all reports, certifications or similar filings required under the Securities Exchange Act of 1934, as amended. 
 ARTICLE 4 
 Section 4.01 No Additional Liability. Nothing in this Coordination Agreement shall impose
any liability or obligation on the part of any party to this Coordination Agreement to make any payment or disbursement in addition to any liability or obligation such party has under the Program Documents, except to the extent that a party has
actually received funds which it is obligated to disburse pursuant to this Coordination Agreement. 
 Section 4.02 No Conflict. This
Coordination Agreement is intended to be in furtherance of the agreements reflected in the documents related to the Program Documents, and not in conflict. To the extent that a provision of this Coordination Agreement conflicts with the provisions
of one or more Program Documents, the provisions of such Program Documents shall govern. 
 Section 4.03 Governing Law. This
Coordination Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to the principles of conflicts of laws thereof. 
  

 D-2 

 Section 4.04 Severability. If any provision in this Coordination Agreement shall be invalid,
illegal or unenforceable, such provision shall be deemed severable from the remaining provisions of this Coordination Agreement and shall in no way affect the validity or enforceability of such other provisions of this Coordination Agreement.

 Section 4.05 Notices. All demands, notices and communications under this Coordination Agreement shall be in writing and shall be
deemed to have been duly given upon receipt at the addresses set forth below: 
 To the Trust: 
 Genworth Global Funding Trust 2006-E 
 c/o The
Bank of New York 
 101 Barclay Street, Floor 8E 
 New York, New York 10286 
 Attention: Corporate Trust Division, Dealing and Trading 
 Facsimile: (212) 815-2850 
 To the
Indenture Trustee: 
 JPMorgan Chase Bank, N.A. 
 227 W. Monroe Street, Suite 2600 
 Chicago, Illinois 60606 
 Attention: Worldwide Securities Services 
 Facsimile: (312) 267-5201 
 To GLAIC: 
 Genworth Life and Annuity Insurance Company 
 6610 West Broad Street 
 Richmond, Virginia 23230 
 Attention:
Treasurer 
 Facsimile: (804) 662-7777 
 with a copy to: 
 Genworth Life and Annuity Insurance Company 
 6610 West Broad Street 
 Richmond, Virginia
23230 
 Attention: Heather Harker, Esq. 
 Facsimile: (804) 281-6005 
 To the Custodian: 
 SunTrust Bank 
 919 East Main Street 
 Richmond, Virginia 23219 
 Attention:
Retirement Services 
 Facsimile: (804) 782-7439 
  

 D-3 

 or at such other address as shall be designated by any such party in a written notice to the other parties. 

Article 5 
 Section 5.01 Pricing
Instrument; Execution and Incorporation of Terms. 
 The parties to this Coordination Agreement will enter into this Coordination
Agreement by executing the Pricing Instrument. 
 By executing the Pricing Instrument, each party hereto agrees that this Coordination
Agreement will constitute a legal, valid and binding agreement by and among the Trust, GLAIC, the Custodian and the Indenture Trustee. 
 All
terms relating to the Trust or the Notes not otherwise included in this Coordination Agreement will be as specified in the Pricing Instrument or Pricing Supplement, as indicated herein. 
 Section 5.02 Counterparts. This Coordination Agreement, through the Pricing Instrument, may be executed in any number of counterparts, each of
which counterparts shall be deemed to be an original, and all of which counterparts shall constitute but one and the same instrument. 
 Section 5.03 Capitalized Terms. All capitalized terms used herein and not otherwise defined in this Coordination Agreement will have the meanings set forth in the Indenture. 
 [Remainder of Page Left Intentionally Blank] 
  

 D-4 

 SECTION E 
 MISCELLANEOUS AND EXECUTION PAGES 
 This Pricing Instrument may be executed by each of the parties hereto in
any number of counterparts, and by each of the parties hereto on separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original, but all such counterparts shall together constitute but one and
the same instrument. 
 Each signatory, by its execution hereof, does hereby become a party to each of the agreements or indenture identified
for such party as of the date specified in such agreements or indenture. 
 IN WITNESS WHEREOF, the undersigned have executed this Pricing
Instrument with respect to the Notes as of the date first written above. 
  

					
	GENWORTH LIFE AND ANNUITY INSURANCE COMPANY (in executing below agrees and becomes a party to (i) the Terms Agreement set forth in Section C herein and (ii) the Coordination
Agreement set forth in Section D herein)
		
	 By:
	 	/s/ Pamela C. Asbury
		 	Name:	 	Pamela C. Asbury
		 	Title:	 	Vice President

 [Execution Page 1 of 3] 
  

 E-1 

					
	THE GENWORTH GLOBAL FUNDING TRUST DESIGNATED IN THIS PRICING INSTRUMENT (in executing below agrees and becomes a party to (i) the Indenture set forth in Section B herein, (ii) the
Terms Agreement set forth in Section C herein and (iii) the Coordination Agreement set forth in Section D herein)
	
	By: The Bank of New York, not in its individual capacity but solely in its capacity as Trustee of the Trust
		
	 By:
	 	/s/ Joseph A. Lloret
		 	Name:	 	Joseph A. Lloret
		 	Title:	 	Assistant Vice President
	
	THE BANK OF NEW YORK (in executing below agrees and becomes a party to the Trust Agreement set forth in Section A herein), as Trustee
		
	 By:
	 	/s/ Joseph A. Lloret
		 	Name:	 	Joseph A. Lloret
		 	Title:	 	Assistant Vice President
	
	THE BANK OF NEW YORK (in executing below acknowledges and agrees to Section 5.01 of the Trust Agreement set forth in Section A herein), in its individual capacity
		
	 By:
	 	/s/ Joseph A. Lloret
		 	Name:	 	Joseph A. Lloret
		 	Title:	 	Assistant Vice President
	
	GSS HOLDINGS II, INC. (in executing below agrees and becomes a party to the Trust Agreement set forth in Section A herein), as Trust Beneficial Owner
		
	 By:
	 	/s/ Andrew L. Stidd
		 	Name:	 	Andrew L. Stidd
		 	Title:	 	Vice President

 [Execution Page 2 of 3] 
  

 E-2 

					
	JPMORGAN CHASE BANK, N.A. (in executing below agrees and becomes a party to (i) the Indenture set forth in Section B herein, as Indenture Trustee, Registrar, Transfer Agent, Paying
Agent and Calculation Agent and (ii) the Coordination Agreement set forth in Section D herein), as Indenture Trustee, Registrar, Transfer Agent, Paying Agent and Calculation Agent
		
	 By:
	 	 /s/ R. Tarnas

		 	Name:	 	R. Tarnas
		 	Title:	 	Authorized Officer
	
	SUNTRUST BANK (in executing below agrees and becomes a party to the Coordination Agreement set forth in Section D herein), as Custodian
		
	 By:
	 	 /s/ Richard J. Owens III

		 	Name:	 	Richard J. Owens III
		 	Title:	 	AVP/Trust Officer
	
	MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED (in executing below agrees and becomes a party to the Terms Agreement set forth in Section C herein)
		
	 By:
	 	 /s/ Teresa A. Radzinski

		 	Name:	 	Teresa A. Radzinski
		 	Title:	 	Managing Director

 [Execution Page 3 of 3] 
  

 E-3 

 EXHIBIT A 
 Standard Trust Terms 
 As filed as Exhibit 4.5 to the Registration Statement on Form S-3 (File No. 333-128718), filed
by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on December 8, 2005. 

 

 A-1 

 EXHIBIT B 
 Standard Indenture Terms 
 As filed as Exhibit 4.1 to the Registration Statement on Form S-3 (File No. 333-128718),
filed by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on December 8, 2005.

  

 B-1 

 EXHIBIT C 
 Pricing Supplement 
 As filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act,
dated as of September 18, 2006, with respect to the Notes to be issued by the Trust. 
  

 C-1 

 EXHIBIT D 
 Genworth Life and Annuity Insurance Company 
 Officer’s Certificate 
 The undersigned, an officer of Genworth Life and Annuity Insurance Company, a stock life insurance company operating under a charter granted by the
Commonwealth of Virginia (“GLAIC”), does hereby certify to Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., in such capacity and on behalf of GLAIC, to the knowledge of the undersigned and
after reasonable inquiry, that: 
  

	 	1.	each of the representations and warranties of GLAIC contained in each Expense and Indemnity Agreement entered into in connection with the Registration Statement (defined below), and
each Funding Agreement issued in connection with the Program (the “Specified Agreements”) (other than any representation or warranty expressly made as of a date prior to the date hereof) are true and correct on and as of the date hereof,
with the same effect as though such representation or warranty had been made on and as of the date hereof; 

  

	 	2.	no default under any of the Specified Agreements and no event or any condition which, with notice or lapse of time or both, would become a default, has occurred and is continuing as
of the date hereof; 

  

	 	3.	GLAIC has performed and complied with, in all material respects, all of the agreements, covenants, obligations and conditions applicable to GLAIC required by the Specified
Agreements to be performed or complied with by GLAIC on or before the date hereof; 

  

	 	4.	the Registration Statement filed on Form S-3 (File No. 333-128718) (the “Registration Statement”) by GLAIC has been declared effective by the Securities and Exchange
Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Act”) and no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for that purpose have been
commenced by or are pending before or contemplated by the Commission; 

  

	 	5.	all filings, if any, required by Rule 424 and Rule 430A under the Act have been made in a timely manner; 

  

	 	6.	since [l]1, the Trusts organized in connection with the program contemplated by the Registration Statement have issued the following series of Notes:

 [List each series of Notes] [(collectively, the “Designated Notes”)]; and 
  

	 	7.	the Funding Agreements issued in connection with the Designated Notes have been executed and delivered by GLAIC in accordance with the terms and conditions of the Program Documents.

	1	This certificate to be signed quarterly. 

  

 D-1 

 Capitalized terms used herein and not otherwise defined herein shall have the meanings set forth in the
Standard Indenture Terms attached as Exhibit 4.1 to the Registration Statement. 
 IN WITNESS WHEREOF, the undersigned has executed this
Certificate as of the [l] day of [l]
200[l]. 
  

					
	[Name], in [his/her] capacity as an authorized officer of Genworth Life and Annuity Insurance Company
		
	 By:
	 	  
		 	Name:	 	
		 	Title:	 	

  

 D-2 

 EXHIBIT E 
 Genworth Global Funding Trusts 
 Trustee Officer’s Certificate 
 The Bank of New York, not in its individual capacity but solely in its capacity as trustee acting on behalf of each common law trust organized under the
laws of the State of Illinois (in such capacity, the “Trustee,” and each such common law trust being referred to herein as a “Trust”) in connection with the program contemplated by the Registration Statement filed on Form S-3
(File No. 333-128718) by Genworth Life and Annuity Insurance Company with the Securities and Exchange Commission (the “Commission”) on September 30, 2005, as amended by Amendment No. 1, filed with the Commission on
December 8, 2005 (the “Registration Statement”), does hereby certify to Standard & Poor’s Ratings Services, a division of The McGraw-Hill Companies, Inc., in such capacity and on behalf of each Trust, to the knowledge of
the Trustee without any independent investigation, that: 
  

	 	1.	each of the representations and warranties of each Trust contained in the Notes issued in connection with the Program, each Indenture entered into in connection with the
Registration Statement and the Expense and Indemnity Agreement concerning the Trusts (the “Specified Agreements”) (other than any representation or warranty expressly made as of a date prior to the date hereof) are true and correct on and
as of the date hereof, with the same effect as though such representation or warranty had been made on and as of the date hereof; 

  

	 	2.	no default under any of the Specified Agreements and no event or any condition which, with notice or lapse of time or both, would become a default, has occurred and is continuing as
of the date hereof; 

  

	 	3.	each Trust has performed and complied with, in all material respects, all of the agreements, covenants, obligations and conditions applicable to such Trust required by the Specified
Agreements to be performed or complied with by such Trust on or before the date hereof; 

  

	 	4.	the Notes issued in connection with the Program have been issued, in all material respects, in accordance with the terms and conditions of the Program Documents; and

  

	 	5.	each Funding Agreement has been executed and delivered by the related Trust in accordance with the terms and conditions of the Program Documents. 

 Capitalized terms used herein and not otherwise defined herein shall have the meanings set forth in the Standard Indenture Terms attached as Exhibit 4.1
to the Registration Statement. In no event shall The Bank of New York in its personal corporate capacity (or any officer of the Trustee in his or her personal capacity) have any liability for any of the certifications or statements contained in this
Trustee Officer’s Certificate, such liability being solely that of each Trust. 
  

 E-1 

 IN WITNESS WHEREOF, the undersigned has executed this Certificate as of the [l] day of [l], 200[l]. 
  

					
	The Bank of New York, not in its individual capacity but solely in its capacity as Trustee acting on behalf of each Trust
		
	 By:
	 	  
		 	Name:	 	
		 	Title:	 	

  

 E-2 

 SCHEDULE I 
 Terms Agreement Specifications 
 In connection with Section 3(a)(iv) of the Distribution Agreement, the Program under
which the Notes are issued is rated Aa3 by Moody’s Investors Service, Inc. (“Moody’s”) and AA- by Standard & Poor’s Rating Services, a division of The McGraw-Hill Companies, Inc. (“S&P”). Genworth Life
and Annuity Insurance Company (“GLAIC”) expects that the Notes will be rated Aa3 by Moody’s and AA- by S&P. GLAIC’s financial strength rating is Aa3 by Moody’s and AA- by S&P. 
 In accordance with Section 2.02(b) of the Terms Agreement and in connection with the purchase of Notes from the Trust by the Agent(s) as principal, the following
items will be delivered on or prior to the Settlement Date: None. 
 All capitalized terms used herein and not otherwise defined herein will
have the meanings set forth in the Distribution Agreement. 
  

 I-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]